[Use of cloridarol in coronary insufficiency].
The therapeutical activity of a new oral drug with a coronaric and myocardiotrophic action of choice, 2-benzofuryl-p-chlorophenyl-carbinol (Menacor, Menarini) in 20 patients with chronic coronary insufficiency was studied by administering 750 mg/day for at least 20 days. General and gastroenteric tolerance was excellent, while good or fair therapeutic results were obtained in 16 cases (80%). It is felt that the drug can be usefully employed in the management of coronary insufficiency.
D000368:Aged; D001572:Benzofurans / Q000627:therapeutic use*; D001592:Benzyl Alcohols / Q000627:therapeutic use; D003327:Coronary Disease / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D014665:Vasodilator Agents / Q000627:therapeutic use*
D001572:Benzofurans; D001592:Benzyl Alcohols; D014665:Vasodilator Agents; C002971:cloridarol
Impiego del cloridarol nell'insufficienza coronarica